{"database": "lobbying", "table": "lobbying_activities", "rows": [[1582369, "e5022312-9ea8-42e2-9963-4bf0eb73e973", "Q3", "HOLLAND & KNIGHT LLP", 18466, "SHIRE PHARMACEUTICALS, INC", 2014, "third_quarter", "HCR", "Worked with congressional offices on issues regarding the challenges of developing products for rare diseases.  Met with Congress regarding \"21st Century Cures,\" including company presentation.  Met with Congress regarding DEA issues.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2014-10-07T15:50:39.857000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1582369"], "units": {}, "query_ms": 74.85836499836296, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}